Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSGU) Share-based Compensation (2023 - 2025)

Historic Share-based Compensation for BrightSpring Health Services (BTSGU) over the last 3 years, with Q3 2025 value amounting to $17.2 million.

  • BrightSpring Health Services' Share-based Compensation rose 1341.22% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.7 million, marking a year-over-year increase of 2227.99%. This contributed to the annual value of $69.2 million for FY2024, which is 166599.44% up from last year.
  • Latest data reveals that BrightSpring Health Services reported Share-based Compensation of $17.2 million as of Q3 2025, which was up 1341.22% from $22.8 million recorded in Q2 2025.
  • Over the past 5 years, BrightSpring Health Services' Share-based Compensation peaked at $24.8 million during Q1 2024, and registered a low of $450000.0 during Q1 2023.
  • Over the past 3 years, BrightSpring Health Services' median Share-based Compensation value was $15.1 million (recorded in 2024), while the average stood at $11.7 million.
  • As far as peak fluctuations go, BrightSpring Health Services' Share-based Compensation soared by 542177.78% in 2024, and later crashed by 3689.23% in 2025.
  • Over the past 3 years, BrightSpring Health Services' Share-based Compensation (Quarter) stood at $1.8 million in 2023, then skyrocketed by 669.4% to $14.0 million in 2024, then rose by 23.39% to $17.2 million in 2025.
  • Its Share-based Compensation stands at $17.2 million for Q3 2025, versus $22.8 million for Q2 2025 and $15.7 million for Q1 2025.